Text and Data Mining valid from 2019-11-21
Received: 15 July 2019
Accepted: 7 November 2019
First Online: 21 November 2019
: S.S. has received compensation for lectures and/or advisory board membership from Merck and SanofiGenzyme. M.A. has received compensation for lectures and/or advisory board membership from Biogen, Genzyme, and Novartis. C.M. has received honoraria for lectures and advisory board membership from Biogen, Merck, Novartis, and SanofiAventis. V.K. and M.V. are employees of Fujirebio Europe N.V. K.B. holds the Torsten Söderberg Professorship, has served as a consultant or on advisory boards for Alzheon, BioArctic, Biogen, Eli Lilly, Fujirebio Europe, IBL International, Merck, Novartis, Pfizer, and Roche Diagnostics and is a cofounder of Brain Biomarker Solutions in Gothenburg AB, a GU Ventures-based platform company at the University of Gothenburg. HZ is a Wallenberg Academy Fellow, a cofounder of Brain Biomarker Solutions in Gothenburg A.B., a GU Ventures-based platform company at the University of Gothenburg, and has served on advisory boards for Roche Diagnostics, Wave, Samumed and CogRx. J.L. has received travel support and/or lecture honoraria from Biogen, Novartis, Teva, and Genzyme/SanofiAventis; has served on scientific advisory boards for Almirall, Teva, Biogen, Novartis, and Genzyme/SanofiAventis; serves on the editorial board of the Acta Neurologica Scandinavica; and has received unconditional research grants from Biogen, Novartis, and Teva. ÅS and LN declare no conflicts of interest.